New drug TB006 aims to ease movement problems in Parkinson's
NCT ID NCT06773962
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 2a trial tests whether the drug TB006 can safely improve motor function in people with early-stage Parkinson's disease. About 62 participants will receive either TB006 or a placebo by IV infusion. The study is double-blind, meaning neither patients nor doctors know who gets the real drug. Researchers will measure changes in movement and check for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TB006 (a drug given by IV infusion)
- What this could lead to
- If it works, this could point toward a new treatment to improve motor function in early-stage Parkinson's disease.
- What could go wrong
- This is a small, early-phase trial with only 62 participants. The drug may not improve symptoms or could cause side effects. Results may not apply to all Parkinson's patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel Rocky Mountain Clinical Research
Englewood, Colorado, 80113, United States
-
Central Texas Neurology Consultants
Round Rock, Texas, 78681, United States
-
Consultants in Neurology, Ltd
Northbrook, Illinois, 60062, United States
-
Josephson Wallack Munshower Neurology - Southeast
Indianapolis, Indiana, 46256, United States
-
NYU Langone Health
Patchogue, New York, 11772, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, 33486, United States
-
Parkinson's Research Centers of America - Long Island
Commack, New York, 11725, United States
-
Parkinson's Research Centers of America - Orange County
Aliso Viejo, California, 92656, United States
-
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California, 94301, United States
-
Quest Research Institute
Farmington Hills, Michigan, 48334, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of South Florida Parkinson's and Movement Disorders Center
Tampa, Florida, 33613, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gene therapy rewire brain cells to ease Parkinson's?
- New sleep drug aims to help Parkinson's patients get a good Night's rest
- Music that moves you: personalized beats may improve walking in Parkinson's
- Dance may retrain the brain: new study tests rhythmic movement for Parkinson's and cognitive decline
- One-Time brain injection targets genetic form of Parkinson's
- Spinal zap showdown: which pattern best helps Parkinson's patients walk?